​

Funding Round

Series C - GrayBug

Series C - GrayBug

Investment Firm

Overview

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Announced Date

Aug 20, 2019

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

C-Bridge Capital

C-Bridge Capital

C-Bridge Capital is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

3

Investor Name
Participant InvestorC-Bridge Capital
Participant InvestorOrbiMed
Participant InvestorHatteras Venture Partners

Round Details and Background

GrayBug raised $80000000 on 2019-08-20 in Series C

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 16, 2015
Debt Financing - GrayBug
-750.0K
Mar 06, 2015
Series A - GrayBug
2-1.7M
Oct 07, 2014
Venture Round - GrayBug
-750.0K
Oct 29, 2013
Series A - GrayBug
2-1.5M

Recent Activity

There is no recent news or activity for this profile.